Astral Codex Ten Podcast feed 2024年07月17日
Did a Melatonin Patent Inspire Current Dose Confusion?
index_new5.html
../../../zaker_core/zaker_tpl_static/wap/tpl_guoji1.html

 

MIT科学家发现褪黑素助眠作用后,申请了合理剂量专利。然而,FDA将其列为膳食补充剂,未加严格监管,导致厂商为规避专利和追求利润,生产远超推荐剂量的高含量褪黑素产品。

🧪褪黑素的发现:MIT科学家揭示了褪黑素在调节睡眠中的作用,并为其在合理剂量下的应用申请了专利。

🛑监管缺失:FDA未将褪黑素作为激素进行监管,而是归类为膳食补充剂,导致其市场缺乏有效监管。

📈市场乱象:药厂为绕过专利和追求更大利益,生产了远高于推荐剂量(1mg)的褪黑素产品,误导消费者认为剂量越高效果越好。

Yesterday I wrote about melatonin, mentioning that most drugstore melatonin supplements were 10x or more the recommended dose. A commenter on Facebook pointed me to an interesting explanation of why.

Dr. Richard Wurtman, an MIT scientist who helped discover melatonin’s role in the body and pioneer its use as a sleep aid, writes:

MIT was so excited about our research team’s melatonin-sleep connection discovery that they decided to patent the use of reasonable doses of melatonin—up to 1 mg—for promoting sleep.

But they made a big mistake. They assumed that the FDA would want to regulate the hormone and its use as a sleep therapy. They also thought the FDA wouldn’t allow companies to sell melatonin in doses 3-times, 10-times, even 15-times more than what’s necessary to promote sound sleep.

Much to MIT’s surprise, however, the FDA took a pass on melatonin. At that time, the FDA was focusing on other issues, like nicotine addiction, and they may have felt they had bigger fish to fry.

Also, the FDA knew that the research on melatonin showed it to be non-toxic, even at extremely high doses, so they probably weren’t too worried about how consumers might use it. In the end, and as a way of getting melatonin on to the market, the FDA chose to label it a dietary supplement, which does not require FDA regulation. Clearly, this was wrong because melatonin is a hormone, not a dietary supplement.

Quickly, supplement manufacturers saw the huge potential in selling melatonin to promote good sleep. After all, millions of Americans struggled to get to sleep and stay asleep, and were desperate for safe alternatives to anti-anxiety medicines and sleeping pills that rarely worked well and came with plenty of side effects.

Also, manufacturers must have realized that they could avoid paying royalties to MIT for melatonin doses over the 1 mg measure. So, they produced doses of 3 mg, 5 mg, 10 mg and more! Their thinking–like so much else in our American society–was likely, “bigger is better!” But, they couldn’t be more wrong.

So he’s saying that…in order to get around a patent on using the correct dose of melatonin…supplement manufacturers…used the wrong dose of melatonin? I enjoy collecting stories of all the crazy perversities created by our current pharmaceutical system, but this one really takes the cake.

Fish AI Reader

Fish AI Reader

AI辅助创作,多种专业模板,深度分析,高质量内容生成。从观点提取到深度思考,FishAI为您提供全方位的创作支持。新版本引入自定义参数,让您的创作更加个性化和精准。

FishAI

FishAI

鱼阅,AI 时代的下一个智能信息助手,助你摆脱信息焦虑

联系邮箱 441953276@qq.com

相关标签

褪黑素 市场策略 FDA监管 专利漏洞
相关文章